Projects per year
Personal profile
Headline
CLINICAL PROFESSOR
Fingerprint
Dive into the research topics where Howard Fillit is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 15 Finished
-
-
-
-
IMMUNOBIOLOGY OF AUTOIMMUNITY TO HEPARAN SULFATE
National Institute of Allergy and Infectious Diseases
1/10/90 → 30/09/97
Project: Research
-
SPECIFICITY OF HUMAN AUTOANTIBODIES TO PROTEOGLYCANS
National Institute of Allergy and Infectious Diseases
1/01/90 → 31/12/93
Project: Research
-
Alzheimer's disease medication use and adherence patterns by race and ethnicity
Olchanski, N., Daly, A. T., Zhu, Y., Breslau, R., Cohen, J. T., Neumann, P. J., Faul, J. D., Fillit, H. M., Freund, K. M. & Lin, P. J., 2022, (Accepted/In press) In: Alzheimer's and Dementia.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer’s disease
Alzheimer’s Disease Neuroimaging Initiative, Jul 2022, In: Nature Aging. 2, 7, p. 616-634 19 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Author Correction: FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease (Nature Communications, (2020), 11, 1, (411), 10.1038/s41467-019-13962-0)
The Alzheimer Disease Neuroimaging Initiative, Dec 2022, In: Nature Communications. 13, 1, 4006.Research output: Contribution to journal › Comment/debate
Open Access -
Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task Force
EU/US/CTAD Task Force, Oct 2022, In: The journal of prevention of Alzheimer's disease. 9, 4, p. 569-579 11 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Commentary: Global Alzheimer's disease and Alzheimer's disease related dementia research funding organizations support and engage the research community throughout the COVID-19 pandemic
Meyers, E. A., Amouyel, P., Bovenkamp, D. E., Carrillo, M. C., De Buchy, G. D., Dumont, M., Fillit, H., Friedman, L., Henderson-Begg, G., Hort, J., Murtishaw, A., Oakley, R., Panchal, M., Rossi, S. L., Sancho, R. M., Thienpont, L., Weidner, W. & Snyder, H. M., May 2022, In: Alzheimer's and Dementia. 18, 5, p. 1067-1070 4 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations
Press / Media
-
-A PROMISING TRIAL TARGETS A GENETIC RISK FOR ALZHEIMER'S
2/02/23
2 items of Media coverage
Press/Media
-
Recent Regulatory Decisions Highlight Evolution of the Anti-Amyloid Theory
25/01/23
1 item of Media coverage
Press/Media
-
U.S. agency refuses to grant accelerated approval for experimental Alzheimer's treatment
24/01/23
1 item of Media coverage
Press/Media
-
-ADDF STATEMENT ON FDA DECISION NOT TO GRANT ACCELERATED APPROVAL TO DONANEMAB FOR TREATMENT OF ALZHEIMER'S DISEASE
23/01/23
2 items of Media coverage
Press/Media
-
ADDF STATEMENT ON FDA DECISION NOT TO GRANT ACCELERATED APPROVAL TO DONANEMAB FOR TREATMENT OF ALZHEIMER's DISEASE
20/01/23 → 21/01/23
89 items of Media coverage
Press/Media